HealthStream (HSTM) Q4 2024 earnings summary

Executive summary

• Achieved strong year-over-year growth in all key financial metrics for 2024, including revenue, net income, operating income, and adjusted EBITDA.

• 96% of revenues are subscription-based, providing high predictability and recurring revenue.

• Major product innovation with the launch of the HealthStream Learning Experience (HLX) and expansion of the hStream platform.

• Completed acquisitions of Total Clinical Placement System and The Clinical Hub, expanding clinical rotation management offerings.

• Announced executive leadership promotions to support single platform strategy and operational integration.

Financial highlights

• Full year 2024 revenue increased 4.5% year-over-year to $291.6M; Q4 revenue was $74.2M, up 5.2%.

• Net income for the year rose 31.5% to $20.0M; Q4 net income was $4.9M, up 6.5%.

• Operating income up 32.9% for the year to $21.3M; Q4 operating income was $4.7M, up 10.2%.

• Adjusted EBITDA up 9% for the year to $66.8M; Q4 adjusted EBITDA was $16.2M, up 1.3%.

• Board declared a quarterly dividend of $0.031 per share, a 10.7% increase over the prior quarter.

Outlook and guidance

• 2025 revenue guidance: $302M–$307M (3.6%–5.3% growth), with growth weighted to the second half.

• Net income expected between $19.2M–$21.4M; adjusted EBITDA $70M–$74M.

• Capital expenditures forecasted at $31M–$34M, with $27M–$29M for software investments.

• Gross margin expected to remain around 66%.

• Guidance assumes stable economic conditions and excludes impacts from future acquisitions or asset impairments.